Hypoxia‐induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9‐mediated GSK3β/β‐catenin signalling

QR Code

Hypoxia‐induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9‐mediated GSK3β/β‐catenin signalling

Abstract Background Phosphoglycerate kinase 1 (PGK1) serves as a critical metabolic enzyme in the process of glycolysis and has many nonmetabolic functions in tumour progression. One of the most prevalent malignant tumours is still esophageal squamous cell carcinoma (ESCC), with high recurrence rate...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jia‐cheng Xu, Lin‐feng Wu, Tian‐yin Chen, Yan‐bo Liu, Yi‐fei Zhang, Ping‐hong Zhou, Yi‐qun Zhang
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Clinical and Translational Medicine
Subjects:	β‐catenin signalling pathway esophageal squamous cell carcinoma hypoxia MYH9 PGK1
Online Access:	https://doi.org/10.1002/ctm2.70376
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Regulation of RHBDD1 in the invasion of esophageal cancer cells via ELK3/Wnt/β-catenin signaling pathway
by: Bing Xu, et al.
Published: (2025-07-01)

ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
by: A. S. Kulakova, et al.
Published: (2021-10-01)

Role of E-cadherin and β-catenin in head and neck squamous cell carcinoma
by: A. A. Petrova, et al.
Published: (2024-01-01)

Downregulated MEG3 contributes to tumour progression and poor prognosis in oesophagal squamous cell carcinoma by interacting with miR-4261, downregulating DKK2 and activating the Wnt/β-catenin signalling
by: Ji Ma, et al.
Published: (2019-12-01)

MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt/β-catenin pathway by targeting phospholipase D1
by: Kai-Liang Tang, et al.
Published: (2019-12-01)

Targeting PGK1 as a Novel strategy to regulate the sensitivity of HER2 positive gastric cancer to lapatinib
by: Xiaochen Ni, et al.
Published: (2025-07-01)

β-Catenin: A Key Molecule in Osteoblast Differentiation
by: Edyta Wróbel, et al.
Published: (2025-07-01)

Identification of a de novo MYH9 mutation in a Chinese family with MYH9-related disease
by: Ruimin Cai, et al.
Published: (2025-12-01)

Upregulation of long noncoding RNA RP4 exacerbates hypoxia injury in cardiomyocytes through regulating miR-939/Bnip3/Wnt/β-catenin pathway
by: Jingfeng Rong, et al.
Published: (2019-12-01)

Esophageal cancer and precancerous lesions: focus on resident bacteria and fungi
by: Liping Yuan, et al.
Published: (2025-07-01)

Hoxc13/β-catenin Correlation with Hair Follicle Activity in Cashmere Goat
by: Jiang-hong WU, et al.
Published: (2012-07-01)

Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
by: Shu Huang, et al.
Published: (2025-02-01)

Disulfiram inhibits migration, invasion and epithelial-mesenchymal transition of gastric cancer cells via β-catenin/CTSB pathway
by: XianYi Zhou, et al.
Published: (2025-12-01)

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021
by: Pietari Junkala, et al.
Published: (2025-08-01)

The antiarthritic effect of CBR‐470‐1 in hypoxic environment is to increase the level of NOD‐like receptor family pyrin domain containing 3 ubiquitination by decreasing phosphoglycerate kinase 1 activity
by: Ao Duan, et al.
Published: (2025-01-01)

The umbilical cord blood exosome MFG-E8 alleviates hypoxic-ischemic encephalopathy brain injury in neonatal rats by restoring autophagy flux and inhibiting ferroptosis through GSK3β/β-catenin signaling
by: Menghua Zhao, et al.
Published: (2025-12-01)

Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?
by: D. A. Chichevatov, et al.
Published: (2024-05-01)

LINC00908 Inactivates Wnt/β‐Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2
by: Han Guan, et al.
Published: (2025-05-01)

Cyclin D1 regulates osteoarthritis chondrocyte apoptosis via WNT3/β-catenin signalling
by: Yi-Yue Chen, et al.
Published: (2019-12-01)

Chemo-immunotherapy sequential with radiotherapy in advanced or metastatic esophageal squamous cell carcinoma
by: Xiang Han, et al.
Published: (2025-12-01)

Immunotherapy in advanced esophageal squamous cell cancer: earlier or later?
by: Shuang Wei, et al.
Published: (2025-07-01)

Wnt/β-catenin signaling pathway role in the endometriosis pathogenesis
by: E. V. Virivskaya, et al.
Published: (2020-04-01)

Giant esophageal liposarcoma with squamous cell carcinoma resected via the cervical approach: a case report
by: Tomohiro Okura, et al.
Published: (2022-06-01)

Nimotuzumab plus chemotherapy and immunotherapy as first-line/neoadjuvant therapy for advanced esophageal squamous cell carcinoma
by: Qi Wang, et al.
Published: (2025-07-01)

A case of long-term survival after surgical resection for solitary adrenal recurrence of esophageal squamous carcinoma
by: Nobuhiko Kanaya, et al.
Published: (2017-05-01)

YAP as a therapeutic target in esophageal squamous cell carcinoma: insights and strategies
by: Weilong Wang, et al.
Published: (2025-12-01)

Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi‐institutional study
by: Fumiaki Shiratori, et al.
Published: (2025-07-01)

Dual Targeting of Inflammatory and Immune Checkpoint Pathways to Overcome Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma
by: Qu Z, et al.
Published: (2025-07-01)

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
by: Xu‐Wei Cai, et al.
Published: (2018-06-01)

Pulmonary metastasectomy for esophageal basaloid squamous cell carcinoma component at 66 months after esophagectomy
by: Kumiko Sekiguchi, et al.
Published: (2020-08-01)

Selective Dual Inhibition of TNKS1 and CDK8 by TCS9725 Attenuates STAT1/β-Catenin/TGFβ1 Signaling in Renal Cancer
by: Majed Saad Al Fayi, et al.
Published: (2025-06-01)

Immunohistochemical Assessment of Maspin, β-Catenin, and MMP-14 in Oral Potentially Malignant Lesions and Oral Squamous Cell Carcinoma: A Retrospective Observational Study
by: Oana Mihaela Condurache Hrițcu, et al.
Published: (2025-06-01)

Alendronate nanoparticles promote fracture healing by inhibiting LRP4 to activate the Wnt/β-catenin pathway
by: ZW Sun, et al.
Published: (2025-06-01)

Tailored Management of Advanced Esophageal Squamous Cell Carcinoma — Balancing Efficacy and Toxicity with a “Hold Chemotherapy and Keep Immunotherapy” Strategy: A Case Report
by: Yu-Chieh Lin, et al.
Published: (2025-04-01)

Brusatol Inhibits Esophageal Squamous Cell Carcinoma Tumorigenesis Through Bad-Mediated Mitochondrial Apoptosis Induction and Anti-Metastasis by Targeting Akt1
by: Yao Ji, et al.
Published: (2025-06-01)

Wnt/β-Catenin Signalling during Liver Metabolism, Chronic Liver Disease and Hepatocarcinogenesis
by: Gayatri D Shirolkar, et al.
Published: (2018-03-01)

Neogambogic Acid Suppresses Characteristics of Colorectal Cancer Stem Cells Through Inhibition of Wnt/β-catenin Signaling Pathway
by: Hao WANG, et al.
Published: (2025-07-01)

Efficacy and safety of camrelizumab plus Lacticaseibacillus paracasei in the treatment of advanced esophageal squamous cell carcinoma: A single-arm, single-center, exploratory trial
by: Tengfei Zhang, et al.
Published: (2025-07-01)

Inhibition of Migration of SW-480 Cells Induced by Royal Jelly Due to Reduction of β-Catenin
by: Milena Jovanović, et al.
Published: (2024-12-01)

SGK2 promotes hepatocellular carcinoma progression and mediates GSK-3β/β-catenin signaling in HCC cells
by: Junying Liu, et al.
Published: (2017-06-01)